Edgewise Therapeutics, Inc. (EWTX) Tops Q3 EPS by 1c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q3 EPS of ($0.36), $0.01 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
• Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming
• Faraday Future reveals robot lineup and new products at Automate